The World Dermatological Market Outlook
2010-2024
| Product Code | VIS00100 |
| Publication Date | November 2009 |
| Publisher | Visiongain |
| Product Type | Report |
| Pages | 142 |
| ISBN Number | not applicable |
The World Dermatological Market Outlook
2010-2024
The World Dermatological Market Outlook 2010-2024 - where will the main commercial opportunities lie in the treatment of skin disorders? Our new pharma market report explains
The dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasing disease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects of pharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The World Dermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developments will lie during our forecast period. And how you can benefit from this expansion.
In particular, this study examines markets for treating the following skin disorders:
- Dermatitis
- Skin infections
- Acne
- Psoriasis.
Also covered are the following dermatological conditions:
- Alopecia
- Rosacea.
What types of therapeutic agent are likely to enter the market from 2010 onwards, and will they hold the potential to dominate this market area? Where will the best commercial opportunities in skin disorders lie from 2010 onwards? What are the most-crucial drivers and restraints in the global dermatological market? This report will provide you with the information that you need to understand current trends and future directions in pharmacological dermatology. In particular, we discuss commercial prospects for the following products in detail, from the present forward:
- Medrol
- Celestone
- Protopic
- Elocon
- Aldara
- Zovirax
- Lamisil
- Solodyn
- Differin
- BenzaClin
- Diane
- Daivobet
- Taclonex
- Dovonex
- Propecia
- Doryx
- Surgicel
Comprehensive analysis of the global dermatology market
The World Dermatological Market Outlook 2010-2024 critically examines that sector through a comprehensive review of primary and secondary information sources. Our new report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included, as well as two full interviews with relevant experts. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.
Why you should buy The World Dermatological Market Outlook 2010-2024
In this report, you will receive the following benefits in particular:
- You will assess the current market for dermatological drugs
- You will review the overall dermatological market, including a global sales forecast
- You will receive sales forecasts for the main dermatological submarkets, with detailed discussions
- You will receive sales forecasts for the leading products in those submarkets with discussions of market potential and competition
- You will receive sales forecasts for leading geographical markets, with informed discussion
- You will examine commercial drivers and restraints in depth
- You will discover the most-exciting pipeline developments in the sector
- You will discover expert opinions from our original interviews with authorities in industry and academia.
You can obtain this report today
Nobody with an interest in the dermatological market should overlook this new study. We predict that total revenues will increase during our forecast period, 2010 to 2024. With rising disease prevalence, expanding patient populations and clear unmet needs, this therapeutic area holds significant potential for further revenue growth and technological innovation. Do you want to harness those opportunities? You can stay ahead by ordering this report today.
Contents
- Chapter 1. Executive Summary
- 1.1 Dermatological Market Review
- 1.2 Aims, Scope and Format of the Report
- Chapter 2. An Introduction to Dermatological Diseases and Treatments
- 2.1 An Introduction to Dermatology
- 2.1.1 The Structure of the Skin
- 2.1.2 Hair
- 2.1.3 Nails
- 2.1.4 Sweat and Serbacous Glands
- 2.2.1 Protection
- 2.2.2 Sensation
- 2.2.3 Vitamin D Synthesis
- 2.2.4 Temperature Regulation and Heat Insulation
- 2.2.5 Storage
- 2.2.6 Prevention of Water Loss
- 2.3 Common Skin Diseases
- 2.4 An Introduction to Acne Vulgaris
- 2.4.1 Acne Conglobata
- 2.4.2 Acne Fulminans
- 2.4.3 Gram-Negative Folliculitis
- 2.4.4 Pyoderma Faciale
- 2.4.5 Causes of Acne
- 2.5 An Introduction to Dermatitis
- 2.5.1 Atopic Dermatitis
- 2.5.2 Contact Dermatitis
- 2.5.3 Seborrheic Dermatitis
- 2.5.4 Nummular Dermatitis
- 2.5.5 Perioral Dermatitis
- 2.6 An Introduction to Psoriasis
- 2.6.1 Plaque Psoriasis
- 2.6.2 Guttate Psoriasis
- 2.6.3 Pustular Psoriasis
- 2.6.4 Inverse Psoriasis
- 2.6.5 Erythrodermic Psoriasis
- 2.7 An Introduction to Rosacea
- 2.7.1 Erythematotelangiectatic Rosacea
- 2.7.2 Papulopustular Rosacea
- 2.7.3 Phymatous Rosacea
- 2.7.4 Ocular Rosacea
- 2.8 An Introduction to Alopecia
- 2.8.1 Alopecia Areata
- 2.8.2 Alopecia Totalis
- 2.8.3 Alopecia Universalis
- 2.8.4 Androgenetic Alopecia
- 2.8.5 Alopecia Barbae
- 2.8.6 Alopecia Mucinosa
- 2.8.7 Traction Alopecia
- 2.8.8 Anagen Effluvium
- 2.8.9 Telogen Effluvium
- 2.9 An Introduction to Infectious Diseases of the Skin
- 2.9.1 Bacterial Skin Infections
- 2.9.1.1 Impetigo
- 2.9.1.2 Folliculitis
- 2.9.1.3 Cellulitis
- 2.9.1.4 Furunculosis
- 2.9.1.5 Carbuncle
- 2.9.2 Fungal Skin Infections
- 2.9.2.1 Tinea Pedis (Athlete's Foot)
- 2.9.2.2 Tinea Unguium (Ringworm of the Nails)
- 2.9.2.3 Tinea Corporis (Ringworm of the skin)
- 2.9.2.4 Tinea Capitis (Scalp Ringworm)
- 2.9.2.5 Kerions
- 2.9.3 Viral Skin Infections
- 2.9.3.1 Molluscum Contagiosum
- 2.9.3.2 Warts
- 2.9.3.3 Herpes Simplex
- 2.9.3.4 Chickenpox
- 2.9.3.5 Herpes Zoster
- 2.10 Common Skin Treatments
- 2.10.1 Creams and Semisolid Emulsions
- 2.10.2 Ointments
- 2.10.3 Lotions
- 2.10.4 Solutions
- 2.10.5 Occlusive Therapy
- 2.10.6 Cleansing Agents
- 2.10.7 Protecting Powders and Hydrophilic Polymer
- 2.10.8 Anti-Infective Agents
- 2.10.9 Anti-Inflammatory Agents
- Chapter 3. The World Dermatological Market, 2010-2024
- 3.1 The World Dermatological Market in 2009
- 3.2 The World Dermatological Market Forecast, 2010-2024
- 3.3 The Dermatitis Market Dominates the World Dermatological Market
- 3.4 The Psoriasis Market Will Show the Highest Increase in Market Share
- 3.5 Solodny is the Leading Drug in the Dermatological Market in 2009
- 3.6 Dermatological Blockbuster Drugs Will Be Increasingly Rare.
- 3.7 The Future of the Dermatology Market
- 3.8 The World Dermatology Market - Overview
- Chapter 4. The World Dermatitis Market, 2010-2024
- 4.1 The World Dermatitis Market in 2009
- 4.2 The World Dermatitis Market Analysis 2010-2024
- 4.3 Medrol (Methylprednisolone Acetate)
- 4.3.1 Medrol Currently Leads the Dermatitis Market
- 4.3.2 Will Medrol Lead the Dermatitis Market in 2024?
- 4.4 Celestone (Betamethasone)
- 4.4.1 Analysis of Forecast Celestone Sales 2009-2024
- 4.5 Protopic (Tacrolimus)
- 4.5.1 Protopic Will Show an Early Increase in Revenues - But Will It Last?
- 4.6 Elocon (Mometasone Fuorate)
- 4.6.1 Elocon Suffers From Generic Competition
- 4.7 The World Dermatitis Market - Summary
- Chapter 5. The World Infectious Skin Diseases Market, 2010-2024
- 5.1 The World Infectious Skin Diseases Market in 2009
- 5.1.1 Topical Viral Infection Products Lead the Market in 2009
- 5.1.2 In 2009, Dermatological Antifungal Products Account for Half of
- Sales
- 5.2 The World Infectious Skin Disease Market Forecast, 2010-2024
- 5.3 Aldara (Imiquimod)
- 5.3.1 Aldara Leads the Infectious Skin Disease Market in 2009
- 5.3.2 Aldara Will Show An Early Increase in Revenues - But Will It Last?
- 5.4 Zovirax (Aciclovir)
- 5.4.1 Analysis of Forecast Zovirax Sales 2009-2024
- 5.5 Lamisil (Terbinafine)
- 5.5.1 Lamisil is the Leading Dermatological Antifungal Treatment in 2009
- 5.6 The World Infectious Skin Diseases Market - Summary
- Chapter 6. The World Acne Market, 2010 - 2024
- 6.1 The World Acne Market in 2009
- 6.1.1 Products Leading the Acne Market, 2009
- 6.2 The World Acne Market Forecast 2010-2024
- 6.3 Solodyn (Minocycline)
- 6.3.1 Solodyn Currently Leads the World Acne Market
- 6.3.2 Will Solodyn Sales Continue to Grow?
- 6.4 Differin (Adapalene)
- 6.4.1 Sales Forecast for Differin, 2009-2024
- 6.4.2 Differin - Life Cycle Management
- 6.5 BenzaClin (Benzoyl peroxide and Clindamycin)
- 6.5.1 BenzaClin Sales Forecast Analysis 2009-2024
- 6.6 Diane
- 6.6.1 Sales Forecast for Diane, 2009-2024
- 6.7 The World Acne Market - Summary
- Chapter 7. The World Psoriasis Market, 2010-2024
- 7.1 The World Psoriasis Market in 2009
- 7.1.1 Topical Antipsoriasis Treatments Lead the Psoriasis Market in 2009
- 7.2 The World Psoriasis Market Forecast 2010-2024
- 7.3 Daivobet (Calcipotriol & Betamethasone)
- 7.3.1 Daivobet Leads the Psoriasis Market in 2009
- 7.3.2 Daivobet Will Benefit from the Removal of Raptiva from the Market
- 7.4 Taclonex (Calcipotriol & Betamethasone)
- 7.4.1 Sales Forecast for Taclonex, 2009-2024
- 7.5 Dovonex (Calcipotriol)
- 7.5.1 Analysis of Dovonex Sales Forecast, 2009-2024
- 7.6 The World Psoriasis Market - Summary
- Chapter 8. The World Market for Miscellaneous Dermatological Drugs,2010-2024
- 8.1 The Miscelleaneous Dermatological Drug Market in 2009
- 8.2 The Miscelleaneous Dermatological Drug Market Analysis, 2010-2024
- 8.3 Propecia (Finasteride)
- 8.3.1 Revenues of Propecia Will Fall, 2009-2024
- 8.3.2 Other Alopecia Products
- 8.4 Doryx (Doxycycline Hyclate)
- 8.4.1 Forecast Sales of Doryx, 2009-2024
- 8.5 Surgicel
- 8.5.1 Forecast Sales of Surgicel, 2009-2024
- 8.6 The Miscellaneous Market - Summary
- Chapter 9. Issues Affecting the Market for Dermatological Pharmaceuticals
- 9.1 SWOT Analysis of the World Dermatological Market
- 9.2 Market Drivers
- 9.3 Market Restraints
- 9.4 There is Scope for Expansion into Related Markets
- 9.5 Advances in Technology are Likely to Bring Benefits to the Market
- 9.6 Consumer Bargaining Power
- 9.7 Competition in the Dermatological Market Will Become Increasingly Intense
- 9.8 Substitutes
- 9.9 A Discussion of Generic Drugs in This Market - How Great is Their Threat?
- Chapter 10. Dermatological Country Markets
- 10.1 The Dermatological Market - Regional Breakdown
- 10.2 Countries Leading the Dermatological Market, 2008
- 10.3 The Dermatological Market in the Nine Major Country Markets
- 10.3.1 The Dermatological Market in the US
- 10.3.2 The Dermatological Market in Japan
- 10.3.3 The Dermatological Market in Germany
- 10.3.4 The Dermatological Market in France
- 10.3.5 The Dermatological Market in the UK
- 10.3.6 The Dermatological Market in Italy
- 10.3.7 The Dermatological Market in Spain
- 10.3.8 The Dermatological Market in India
- 10.3.9 The Dermatological Market in China
- Chapter 11. The Dermatological Pharmaceutical Pipeline
- 11.1 The Potential of the Dermatological Market Has Encouraged R&D
- 11.2 New Technology in Pipeline Developments
- 11.2.1 Reformulation
- 11.2.2 Combination Treatments
- 11.2.3 New mechanisms
- 11.2.4 Drug Delivery Technology
- 11.3 Potential Entrants
- 11.4 Pipeline Products in the Dermatitis Sector
- 11.5 Pipeline Products in the Infectious Skin Disease Sector
- 11.6 Pipeline Products in the Acne Sector
- 11.7 Pipeline Products in the Psoriasis Sector
- 11.8 Pipeline Products for Miscellaneous Dermatologicals
- 11.9 Innovation Rules for Early-Stage PipelineDrugs
- Chapter 12. Expert Views from Key Opinion Leaders
- 12.1 Interview with the Product Development Director of a Pharmaceutical Company
- 12.1.1 The Future of the Dermatology Market
- 12.1.2 Areas Offering Growth Opportunities
- 12.1.3 Future Development Trend
- 12.1.4 Pipeline Products
- 12.1.5 Unmet Needs in Dermatology
- 12.1.6 Threats Facing the Dermatology Market
- 12.2 Interview With Dr M.J.Thornton, BSc, PhD, Cutaneous Biology Group,
- University of Bradford.
- 12.2.1 Androgen Based Science and Dermatology
- 12.2.2 Key Areas For Dermatological Research
- 12.2.3 Unmet Needs in Dermatology
- 12.2.4 Future Developments
- 12.2.5 Challenges in Dermatology
- Chapter 13. Conclusions
- 13.1 The World Dermatological Market Will Experience Gradual Financial Growth
- 13.2 Market Drivers in the Dermatological Market
- 13.3 Market Restraints in the Dermatological Market
- 13.4 Will The Dermatitis Market Continue to Dominate the Dermatology Market?
- 13.5 The Skin Infection Market Faces Strong Generic Competition - Can it Expand?
- 13.6 Will the Acne Market Share Increase or Decline?
- 13.7 Will Growth of the Psoriasis Market Slow Down?
- 13.8 Why Growth in the Overall World Dermatological Market Will Continue
- List of Tables
- Table 3.1 The World Dermatological Market Forecast, 2009-2016
- Table 3.2 The World Dermatological Market Forecast, 2017-2024
- Table 3.3 Leading Dermatological Markets Forecast, 2009-2016
- Table 3.4 Leading Dermatological Markets Forecast, 2017-2024
- Table 3.5 Market Shares of The Leading Dermatological Markets (%)
- Table 3.6 The Leading Drugs in the World Dermatological Market
- Table 3.7 Leading Companies in the Dermatological Market
- Table 4.1 Total Dermatitis Market Forecast, 2009-2016
- Table 4.2 Total Dermatitis Market Forecast, 2017-2024
- Table 4.3 The World Dermatitis Market Drugs Forecast, 2009-2016
- Table 4.4 The World Dermatitis Market Drugs Forecast, 2017-2024
- Table 4.5 Market Share of the Leading Dermatitis Drugs (%)
- Table 4.6 Leading Dermatitis Products Rank Comparison, 2009 and 2024
- Table 5.1 Total Infectious Skin Diseases Market Forecast, 2009-2016
- Table 5.2 Total Infectious Skin Diseases Market Forecast, 2017-2024
- Table 5.3 Sales of Skin Infection Products by Class (%), 2009
- Table 5.4 The World Infectious Skin Disease Market Drug Forecast,2009-2016
- Table 5.5 The World Infectious Skin Disease Market Drug Forecast,2017-2024
- Table 5.6 Market Share of the Leading Skin Infection Drugs (%)
- Table 5.7 Leading Skin Infection Products Rank Comparison, 2009 and 2024
- Table 6.1 Total Acne Market Forecast, 2009-2016
- Table 6.2 Total Acne Market Forecast, 2017-2024
- Table 6.3 The World Acne Market Drugs Forecast, 2009-2016
- Table 6.4 The World Acne Market Drugs Forecast, 2017-2024
- Table 6.5 Market Share of the Leading Acne Drugs (%)
- Table 6.6 Leading Acne Products Rank Comparison, 2009 and 2024
- Table 7.1 Total Psoriasis Market Forecast, 2009-2016
- Table 7.2 Total Psoriasis Market Forecast, 2017-2024
- Table 7.3 The World Psoriasis Market Drugs Forecast, 2009-2016
- Table 7.4 The World Psoriasis Market Drugs Forecast, 2017-2024
- Table 7.5 Market Share of the Leading Psoriasis Drugs (%)
- Table 7.6 Leading Psoriasis Products Rank Comparison, 2009 and 2024
- Table 8.1 Forecast of the Miscelleanous Market, 2009-2016
- Table 8.2 Forecast of the Miscelleanous Market, 2017-2024
- Table 8.3 World Market Forecast for Miscellaneous Dermatologicals ($m),2008-2016
- Table 8.4 World Market Forecast for Miscellaneous Dermatologicals ($m),2017-2024
- Table 8.5 Market Share of the Leading Miscellaneous Drugs (%)
- Table 8.6 Leading Miscellanous Products Rank Comparison, 2009 and 2024
- Table 9.1 SWOT Analysis of the World Dermatological Market
- Table 10.1 The Dermatological Market Revenues by Region ($m), 2008
- Table 10.2 Countries Leading the Dermatological Market, 2008
- Table 10.3 Dermatological Market Forecast for the Nine Major Country Markets, 2008-2016
- Table 10.4 Dermatological Market Forecast for the Nine Major Country Markets, 2017-2024
- Table 10.5 The Nine Major Country Markets - Market Share (%), 2009, 2014& 2024
- Table 11.1 Key Pipeline Products for the Treatment of Dermatitis
- Table 11.2 Key Pipeline Products for the Treatment of Infectious Skin Diseases
- Table 11.3 Key Pipeline Products for the Treatment of Acne
- Table 11.4 Key Pipeline Products for the Treatment of Psoriasis
- Table 11.5 Key Pipeline Miscellaneous Dermatologicals
- List of Figures
- Figure 3.1 World Dermatological Market Forecast ($m), 2009 - 2024
- Figure 3.2 The Leading Dermatological Markets Revenues ($m) 2009- 2024
- Figure 3.3 Market Share of the Leading dermatological Markets (%),2009-2024
- Figure 3.4 The Leading Drugs in the World Dermatological Market, 2009
- Figure 4.1 World Dermatitis Market Sales ($m), 2009-2024
- Figure 4.2 Leading Dermatitis Drugs Forecast ($m), 2009-2024
- Figure 4.3 Market Share (%) of the Leading Dermatitis Products, 2009
- Figure 4.4 Market Share (%) of the Leading Dermatitis Products, 2014
- Figure 4.5 Market Share (%) of the Leading Dermatitis Products, 2024
- Figure 4.6 Medrol Sales Forecasts ($m), 2009-2024
- Figure 4.7 Celestone Sales Forecast ($m)
- Figure 4.8 Protopic Sales Forecast ($m), 2009-2024
- Figure 4.9 Elocon Sales Forecast ($m), 2009-2024
- Figure 5.1 World Infectious Skin Disease Market Revenues ($m), 2008-2024
- Figure 5.2 Leading Infectious Skin Disease Drugs Forecast ($m), 2009-2024
- Figure 5.3 Market Share (%) of the Leading Skin Infection Products, 2009
- Figure 5.4 Market Share (%) of the Leading Skin Infection Products, 2014
- Figure 5.5 Market Share (%) of the Leading Skin Infection Products, 2024
- Figure 5.6 Aldara Sales Forecasts ($m), 2009-2024
- Figure 5.7 Zovirax Sales Forecasts ($m), 2009-2024
- Figure 5.8 Lamisil Sales Forecasts ($m), 2009-2024
- Figure 6.1 World Acne Market Sales ($m), 2008-2024
- Figure 6.2 Leading Acne Drugs Forecast ($m), 2009-2024
- Figure 6.3 Market Share (%) of the Leading Acne Products, 2009
- Figure 6.4 Market Share (%) of the Leading Acne Products, 2014
- Figure 6.5 Market Share (%) of the Leading Acne Products, 2024
- Figure 6.6 Solodyn Sales Forecast ($m), 2009-2024
- Figure 6.7 Differin Sales Forecasts ($m), 2009-2024
- Figure 6.8 BenzaClin Sales Forecasts ($m), 2009-2024
- Figure 6.9 Diane Sales Forecasts ($m), 2009-2024
- Figure 7.1 World Psoriasis Market Sales ($m), 2009-2024
- Figure 7.2 Leading Psoriasis Drugs Forecast ($m), 2009-2024
- Figure 7.3 Market Share (%) of the Leading Psoriasis Products, 2009
- Figure 7.4 Market Share (%) of the Leading Psoriasis Products, 2014
- Figure 7.5 Market Share (%) of the Leading Psoriasis Products, 2024
- Figure 7.6 Daivobet Sales Forecasts ($m), 2009-2024
- Figure 7.7 Taclonex Sales Forecast ($m), 2009-2024
- Figure 7.8 Dovonex RSales Forecast ($m), 2009-2024
- Figure 8.1 World Market Forecast for Miscellaneous Dermatologicals ($m),2009-2024
- Figure 8.2 Forecast for Leading Drugs in the MiscellaneousDermatologicals Market ($m), 2009 -2024
- Figure 8.3 Market Share (%) of Leading Drugs in the Miscellaneous Dermatologicals Market, 2009
- Figure 8.4 Market Share (%) of Leading Drugs in the Miscellaneous Dermatologicals Market, 2014
- Figure 8.5 Market Share (%) of Leading Drugs in the Miscellaneous Dermatologicals Market, 2024
- Figure 8.6 Propecia Sales Forecast ($m) 2009-2024
- Figure 8.7 Doryx Sales Forecast ($m) 2009-2024
- Figure 8.8 Surgicel Sales Forecast ($m) 2009-2024
- Figure 10.1 Dermatological Market Revenues ($m) and Share (%) by Region
- Figure 10.2 The 10 Countries Leading the Dermatological Market in 2008 -Revenues ($m)
- Figure 10.3 US and Japan Dermatological Market Forecasts, 2009-2024
- Figure 10.4 European, Indian and Chinese Dermatological Market Forecasts, 2009-2024
- Figure 10.5 Dermatological Market Share (%) by Country, 2009
- Figure 10.6 Dermatological Market Share (%) by Country, 2014
- Figure 10.7 Dermatological Market Share (%) by Country, 2024
- Companies Listed
- Abbott
- Almirall
- Altana
- Anacor
- AndroScience
- Astellas
- Astion
- Barr
- Bayer
- Bayer Schering
- Cephalon
- CombinatoRx
- Dr. Reddy's Laboratories
- Ferrer
- Galderma
- Gene Signal International
- GlaxoSmithKline
- Graceway Pharmaceuticals
- Gruenenthal
- Impax Laboratories, Inc
- Incyte
- Intercytex
- Johnson & Johnson
- L'Oreal
- Maruho
- Medicis
- Merck & Co.
- Medivir
- Minnesota 3M
- Moberg Derma
- Morria
- Mylan Pharmaceuticals
- Novartis
- Nestle (Alcon, Galderma)
- Otsuka
- Pfizer
- Pola Pharma
- Sanofi-Aventis
- Schering-Plough
- Shionogi
- Stiefel
- Taisho
- Teva
- Toyama
- Valeant
- Warner Chilcott
- XOMA